Profile data is unavailable for this security.
About the company
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
- Revenue in USD (TTM)76.22m
- Net income in USD-98.51m
- Incorporated2020
- Employees225.00
- LocationButterfly Network Inc1600 District AvenueBURLINGTON 01803United StatesUSA
- Phone+1 (781) 557-4800
- Fax+1 (302) 636-5454
- Websitehttps://www.butterflynetwork.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mesa Laboratories Inc | 228.38m | -245.65m | 547.81m | 736.00 | -- | 3.39 | -- | 2.40 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
Surmodics Inc | 126.08m | -11.54m | 559.12m | 389.00 | -- | 4.72 | -- | 4.43 | -0.8145 | -0.8145 | 8.90 | 8.30 | 0.6922 | 2.20 | 6.03 | 324,108.00 | -6.34 | -3.99 | -7.22 | -4.66 | 73.81 | 80.25 | -9.15 | -6.26 | 3.22 | -3.03 | 0.1991 | -- | -4.91 | 4.73 | -651.43 | -- | -12.34 | -- |
AxoGen Inc | 180.86m | -14.31m | 576.51m | 426.00 | -- | 5.80 | -- | 3.19 | -0.3302 | -0.3302 | 4.16 | 2.26 | 0.9356 | 1.65 | 7.55 | 424,544.60 | -7.40 | -13.92 | -8.49 | -15.84 | 76.13 | 79.74 | -7.91 | -20.28 | 2.47 | -1.50 | 0.3224 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
Simulations Plus Inc | 70.01m | 9.95m | 602.82m | 243.00 | 61.38 | 3.30 | 38.60 | 8.61 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
Standard Biotools Inc | 155.90m | -170.60m | 603.06m | 534.00 | -- | 1.23 | -- | 3.87 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
Orthopediatrics Corp | 189.67m | -28.44m | 641.00m | 247.00 | -- | 1.73 | -- | 3.38 | -1.24 | -1.24 | 8.26 | 15.32 | 0.4116 | 0.4509 | 4.71 | 767,906.90 | -6.17 | -5.40 | -6.78 | -5.93 | 73.68 | 75.09 | -15.00 | -15.92 | 3.68 | -29.23 | 0.1638 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Iradimed Corp | 71.31m | 18.63m | 674.61m | 148.00 | 36.46 | 8.08 | 34.68 | 9.46 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
Varex Imaging Corp | 811.00m | -47.70m | 675.26m | 2.30k | -- | 1.27 | -- | 0.8326 | -1.16 | -1.16 | 19.77 | 13.02 | 0.6576 | 2.04 | 5.05 | 352,608.70 | -3.83 | -0.1231 | -4.54 | -0.146 | 31.68 | 31.59 | -5.82 | -0.1748 | 1.97 | 1.40 | 0.4502 | -- | -9.22 | 0.767 | -198.96 | -- | 6.32 | -- |
Butterfly Network Inc | 76.22m | -98.51m | 700.97m | 225.00 | -- | 3.85 | -- | 9.20 | -0.4708 | -0.4708 | 0.3627 | 0.8537 | 0.2543 | 0.6416 | 4.45 | 338,755.60 | -32.87 | -- | -38.53 | -- | 29.60 | -- | -129.25 | -- | 2.95 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
Orthofix Medical Inc | 784.25m | -119.03m | 713.84m | 1.63k | -- | 1.36 | -- | 0.9102 | -3.14 | -3.14 | 20.72 | 13.76 | 0.8844 | 1.17 | 6.56 | 479,956.60 | -13.42 | -8.88 | -16.31 | -10.96 | 68.05 | 72.37 | -15.18 | -9.28 | 1.11 | -3.12 | 0.2069 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
Figs Inc | 548.65m | 10.84m | 798.70m | 354.00 | 79.82 | 1.98 | 48.23 | 1.46 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
Embecta Corp | 1.12bn | 69.70m | 807.83m | 2.20k | 11.60 | -- | 7.46 | 0.722 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
Castle Biosciences Inc | 311.88m | 6.08m | 808.85m | 610.00 | 144.46 | 1.83 | 41.42 | 2.59 | 0.1999 | 0.1999 | 11.07 | 15.77 | 0.6562 | 9.15 | 7.15 | 511,275.40 | 1.28 | -9.43 | 1.40 | -10.17 | 81.90 | 80.58 | 1.95 | -28.46 | 7.64 | -- | 0.0228 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
Avanos Medical Inc | 681.50m | 21.70m | 828.15m | 3.77k | 38.51 | 0.6734 | 12.25 | 1.22 | 0.4679 | 0.3385 | 14.70 | 26.76 | 0.4031 | 1.90 | 5.16 | 180,721.30 | 1.28 | -0.6527 | 1.45 | -0.7338 | 55.51 | 54.45 | 3.18 | -1.60 | 1.46 | 9.84 | 0.1164 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
Cytek Biosciences Inc | 201.21m | -10.16m | 832.12m | 645.00 | -- | 2.17 | -- | 4.14 | -0.0782 | -0.0782 | 1.52 | 2.97 | 0.3982 | 1.60 | 3.72 | 297,647.90 | -2.01 | -- | -2.29 | -- | 54.92 | -- | -5.05 | -- | 5.47 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Paragon 28 Inc | 245.00m | -63.08m | 870.95m | 430.00 | -- | 6.25 | -- | 3.55 | -0.7599 | -0.7599 | 2.95 | 1.67 | 0.823 | 0.6362 | 7.06 | 569,755.80 | -21.19 | -- | -25.76 | -- | 75.22 | -- | -25.75 | -- | 1.60 | -4.20 | 0.4424 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Glenview Capital Management LLCas of 30 Sep 2024 | 9.96m | 5.35% |
ARK Investment Management LLCas of 30 Sep 2024 | 8.68m | 4.66% |
The Vanguard Group, Inc.as of 30 Sep 2024 | 7.26m | 3.90% |
BlackRock Fund Advisorsas of 30 Sep 2024 | 2.16m | 1.16% |
Renaissance Technologies LLCas of 30 Sep 2024 | 2.09m | 1.12% |
Geode Capital Management LLCas of 30 Sep 2024 | 1.72m | 0.93% |
D. E. Shaw & Co. LPas of 30 Sep 2024 | 1.52m | 0.82% |
ExodusPoint Capital Management LPas of 30 Sep 2024 | 1.29m | 0.70% |
Bill & Melinda Gates Foundation Trust (Investment Management)as of 30 Sep 2024 | 1.01m | 0.54% |
Charles Schwab Investment Management, Inc.as of 30 Sep 2024 | 955.33k | 0.51% |